Sort by
Refine Your Search
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large
-
(ministries, regulators, government-run start-up incubators) and companies in the financial services sector Prepare research proposals to attract industry partnerships as well as national and European grant
-
-mentioned methods Provide guidance to PhD students Disseminate results through scientific publications Prepare research proposals to attract industry partnerships as well as national and European grant
-
researcher to study the complexity and heterogeneity of both mouse and human microglia in neurodevelopment and neurodegeneration. By using state of the art spectral flow cytometry you will develop advanced
-
the training activities and scientific events, in coordinating and updating a scientific blog on legislative and jurisprudential developments and in maintaining contact with DTU-GREITMA's stakeholders Helping
-
flow cytometry you will develop advanced tools to analyse and study microglia phenotype, function and dysfunction. If you are up for a technological challenge to address key biological questions
-
of CLiPS, which focuses on the application of statistical and machine learning methods, trained on corpus data, to explain human language acquisition and processing data, and to develop automatic text
-
researcher to study the complexity and heterogeneity of both mouse and human microglia in neurodevelopment and neurodegeneration. By using state of the art spectral flow cytometry you will develop advanced
-
%) postdoctoral researcher in the field of bio-electrochemistry. The overall goal of this project is to develop novel biosensing strategies that will pave the way to the construction of affordable, robust, and user
-
to develop new carbon capture technologies. We are seeking a motivated postdoc to identify biochemical activities in phytoplankton that convert intracellular metabolites into stable, degradation-resistant